|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,027.51 USD | +1.80% |
|
+1.70% | +33.10% |
| Dec. 12 | Health Care Flat on Defensive Bias - Health Care Roundup | DJ |
| Dec. 12 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
| Capitalization | 920B 784B 732B 689B 1,268B 83,330B 1,385B 8,545B 3,315B 39,280B 3,452B 3,379B 143,308B | P/E ratio 2025 * |
44.9x | P/E ratio 2026 * | 32.5x |
|---|---|---|---|---|---|
| Enterprise value | 945B 805B 752B 708B 1,303B 85,589B 1,423B 8,777B 3,405B 40,345B 3,546B 3,471B 147,194B | EV / Sales 2025 * |
14.9x | EV / Sales 2026 * | 12.2x |
| Free-Float |
99.81% | Yield 2025 * |
0.58% | Yield 2026 * | 0.65% |
Last Transcript: Eli Lilly and Company
| 1 day | +1.80% | ||
| 1 week | +1.70% | ||
| Current month | -4.46% | ||
| 1 month | +0.22% | ||
| 3 months | +36.02% | ||
| 6 months | +25.40% | ||
| Current year | +33.10% |
| 1 week | 977.12 | 1,031.56 | |
| 1 month | 977.12 | 1,111.99 | |
| Current year | 623.78 | 1,111.99 | |
| 1 year | 623.78 | 1,111.99 | |
| 3 years | 302.14 | 1,111.99 | |
| 5 years | 161.78 | 1,111.99 | |
| 10 years | 64.18 | 1,111.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 57 | 2016-12-31 |
Ruth Gimeno
PSD | President | - | - |
Lucas Montarce
DFI | Director of Finance/CFO | 48 | 2024-09-08 |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Fyrwald
BRD | Director/Board Member | 65 | 2004-12-31 |
Ralph Alvarez
BRD | Director/Board Member | 69 | 2009-03-31 |
| Director/Board Member | 53 | 2011-12-11 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.80% | +1.70% | +30.21% | +182.67% | 920B | ||
| +0.75% | +4.78% | +44.31% | +17.70% | 510B | ||
| -0.29% | -1.22% | +28.81% | +35.46% | 395B | ||
| -0.35% | +1.90% | +25.12% | +3.01% | 340B | ||
| -1.12% | -1.09% | +28.43% | +17.93% | 278B | ||
| -0.45% | -1.48% | +20.24% | +22.49% | 254B | ||
| +1.30% | +0.58% | -1.67% | -10.09% | 249B | ||
| +0.45% | +3.73% | -57.41% | -31.49% | 224B | ||
| +0.11% | -3.68% | +17.41% | +17.19% | 171B | ||
| -2.28% | -0.68% | +31.08% | +36.20% | 149B | ||
| Average | -0.01% | +0.45% | +16.65% | +29.11% | 349.14B | |
| Weighted average by Cap. | +0.42% | +1.07% | +22.26% | +57.74% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 63.58B 54.16B 50.59B 47.6B 87.64B 5,759B 95.74B 591B 229B 2,714B 239B 234B 9,903B | 76.3B 65B 60.72B 57.13B 105B 6,911B 115B 709B 275B 3,258B 286B 280B 11,885B |
| Net income | 20.4B 17.38B 16.23B 15.27B 28.12B 1,848B 30.72B 189B 73.49B 871B 76.54B 74.93B 3,177B | 28.05B 23.89B 22.32B 21B 38.66B 2,540B 42.24B 261B 101B 1,197B 105B 103B 4,369B |
| Net Debt | 24.95B 21.25B 19.85B 18.68B 34.39B 2,259B 37.57B 232B 89.88B 1,065B 93.6B 91.63B 3,886B | 10.94B 9.32B 8.7B 8.19B 15.08B 991B 16.47B 102B 39.41B 467B 41.04B 40.18B 1,704B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 1,027.51 $ | +1.80% | 3,275,239 |
| 25-12-11 | 1,009.38 $ | +1.58% | 4,516,960 |
| 25-12-10 | 993.64 $ | +1.16% | 2,966,270 |
| 25-12-09 | 982.22 $ | -1.54% | 2,569,724 |
| 25-12-08 | 997.59 $ | -1.26% | 3,088,557 |
Delayed Quote Nyse, December 12, 2025 at 04:00 pm EST
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LLY Stock
Select your edition
All financial news and data tailored to specific country editions

















